மார்கா ஸுஶார்ட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மார்கா ஸுஶார்ட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மார்கா ஸுஶார்ட் Today - Breaking & Trending Today

Two types of blood pressure meds prevent heart events equally, but side effects differ

Two types of blood pressure meds prevent heart events equally, but side effects differ
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

New York , United States , Columbia University , South Korea , Benton Harbor , Republic Of Korea , Martijnj Schuemie , Nicole Pratt , Harlanm Krumholz , Willie Lawrence , George Hripcsak , Jon Duke , David Madigan , Ruijun Chen , Christiang Reich , Steven Shea , Marca Suchard , Patrickb Ryan , American Heart Association , Ministries Of Health Welfare , National Institute Of Allergy , Geisinger Medical Center , National Science Foundation , Columbia University Vagelos College Of Physicians , National Library Of Medicine , Industry Energy Of The Republic Korea ,

Common high blood pressure drugs do not increase COVID-19 risk

Common high blood pressure drugs do not increase COVID-19 risk
Credit: CC0 Public Domain
While the COVID-19 pandemic left the world searching for answers, one healthcare concern is about the use of certain high blood pressure drugs, and whether the drugs posed increased COVID-19 risks.
In a new study, researchers found that there was no increased risk of COVID-19 diagnosis, hospitalization, or complications for users of either angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) to treat high blood pressure.
They tested more than 1.1 million patients who use high blood pressure drugs.
The findings support recent clinical recommendations that patients should not discontinue ACE inhibitor or ARB therapy due to concerns of increased COVID-19 risk. ....

United States , Marca Suchard , Columbia University Irving Medical Center , Lancet Digital Health , Lancet Digital , ஒன்றுபட்டது மாநிலங்களில் , மார்கா ஸுஶார்ட் , கொலம்பியா பல்கலைக்கழகம் இவிஂக் மருத்துவ மையம் ,

Patients on ACE inhibitors, ARBs, don't have higher COVID-19 risk

Patients on ACE inhibitors, ARBs, don't have higher COVID-19 risk
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United States , Fort Detrick , Marca Suchard , George Hripcsak , Daniel Morales , Spain Columbia University Irving Medical Center , European Network Of Centres , Information System For Research , Department Of Veteran Affairs , Research Facility , Columbia University Department Of Biomedical Informatics , Wellcome Trust Clinical Research , Lancet Digital Health , European Medicines Agency , Observational Health Data Sciences , University Of Dundee , Lancet Digital , Columbia University Irving Medical Center , Veteran Affairs , Information System , Primary Care , European Network , Methodological Standards , Wellcome Trust Clinical Research Fellow , Inhibition Utilization , Columbia University Department ,

Patients on ACE inhibitors, ARBs, don't have higher COVID-19 risk, fFnds study

E-Mail
NEW YORK, NY (Dec. 17, 2020) While the COVID-19 pandemic left the world searching for answers during the earliest stages of the pandemic, one immediate healthcare concern regarded the use of certain antihypertensives and whether they posed increased risks to patients with hypertension.
A new study by global collaborators within the Observational Health Data Sciences and Informatics (OHDSI) community found that there was no increased risk of COVID-19 diagnosis, hospitalization, or subsequent complications for users of either angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) among an international cohort of more than 1.1 million patients using antihypertensives.
The study was published today in ....

United States , Marca Suchard , George Hripcsak , Daniel Morales , Spain Columbia University Irving Medical Center , European Network Of Centres , Information System For Research , Columbia University , Department Of Veteran Affairs , Columbia University Department Of Biomedical Informatics , Wellcome Trust Clinical Research , Lancet Digital Health , European Medicines Agency , Observational Health Data Sciences , University Of Dundee , Lancet Digital , Columbia University Irving Medical Center , Veteran Affairs , Information System , Primary Care , European Network , Methodological Standards , Wellcome Trust Clinical Research Fellow , Inhibition Utilization , Columbia University Department , Biomedical Informatics ,